Loading...

Loading...

INER Adopts AI Software to Enhance Lung Disease Detection
By Sofía Garduño - Fri, 01/16/2026 - 10:37
INER integrates AI into imaging analysis to support early detection of lung cancer and respiratory diseases.
https://mexicobusiness.news/tag/lung-cancer
More Health
Nuevo Leon Launches AI-Based Lung Cancer Screening Program
By Sofía Garduño - Mon, 11/10/2025 - 10:36
Nuevo Leon launches Mexico’s first AI-driven lung cancer screening program for early detection and prevention.
Glenmark Expands Phase 3 Study of Envafolimab to Multiple Regions
By Aura Moreno - Mon, 09/08/2025 - 09:06
Glenmark initiates a multi-country Phase 3 trial of Envafolimab in resectable Stage III non-small cell lung cancer, with enrollment starting in India.
INER, AstraZeneca Launch AI Lung Cancer Detection Imaging
By MBN Staff - Thu, 08/28/2025 - 13:12
INER and AstraZeneca launch AI-powered imaging to boost early lung cancer detection and strengthen respiratory care in Mexico.
FDA Approves BIZENGRI for Lung and Pancreatic Cancer Treatment
By MBN Staff - Wed, 12/11/2024 - 07:52
FDA approves BIZENGRI, the first therapy targeting the NRG1 gene for treating non-small cell lung cancer and pancreatic adenocarcinoma.

FDA Approves J&J’s New Chemo-Free Lung Cancer Therapy
By MBN Staff - Thu, 08/22/2024 - 10:11
Johnson & Johnson's FDA-approved chemotherapy-free NSCLC treatment with Rybrevant and lazertinib offers a new alternative to AstraZeneca's Tagrisso.

Faster Approvals Could Hasten New Drug Introduction in LATAM
By Sofía Garduño - Tue, 07/16/2024 - 17:04
Shortening regulatory approval timelines would benefit the industry and help bring new drugs to market more quickly, says PPD’s Marlene Llópiz Avilés
Cancer Burden Surges, Revealing Access Inequities
By MBN Staff - Thu, 02/15/2024 - 10:29
Cancer cases soar globally, hitting women in poorer nations hardest. In Mexico, access to care remains a top challenge.
 Navigating the Cancer Crisis with Personalized Medicine
By Anmol Motwani - Wed, 10/25/2023 - 11:14
The looming cancer crisis demands personalized medicine, warn oncologists, but its adoption falters due to prohibitive research costs.
How Microbiome Testing Could Predict Diseases, Reduce Costs
By Natalia Diaz - Tue, 07/25/2023 - 01:00
Microbiomes consist of trillions of bacteria, viruses and microorganisms that provide people with significant health benefits, writes Natalia Diaz.